Lawrence Lynn
Columbus, OHNPI 1861486276
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $5,157,778 of the $5,157,778 with a category attached, or 100.0%. BD accounts for 92.5% of it on its own, with 1 other manufacturer making up the rest.
Across 8 payments — averaging $644,722 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$4.8M
- Covidien LP$385K
What the payments were for
- Royalty or licence$5,157,778100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 4 | $4,773,178 |
| Covidien LP | 4 | $384,600 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.